MTOR and cancer: In most of the cancer cells, the PI3K (phosphoinositide 3-kinase)/mTOR (mammalian target of rapamycin) signaling pathway is activated by insulin, thereby up-regulating PKM2 expression through HIF1α-mediated transcription of the PKM gene (6, 9, 16, 32, 34).